Cyclo Therapeutics, Inc.

NASDAQ (USD): Cyclo Therapeutics, Inc. (CYTH)

Last Price

1.01

Today's Change

+0.24 (31.16%)

Day's Change

0.97 - 1.45

Trading Volume

76,498,608

Overview

Market Cap

29 Million

Shares Outstanding

28 Million

Avg Volume

45,853

Avg Price (50 Days)

0.68

Avg Price (200 Days)

0.95

PE Ratio

-1.13

EPS

-0.90

Earnings Announcement

17-Mar-2025

Previous Close

0.77

Open

1.34

Day's Range

0.97 - 1.45

Year Range

0.55 - 1.92

Trading Volume

76,523,330

Price Change Highlight

1 Day Change

31.17%

5 Day Change

33.33%

1 Month Change

55.38%

3 Month Change

40.98%

6 Month Change

-12.93%

Ytd Change

68.33%

1 Year Change

-42.94%

3 Year Change

-71.79%

5 Year Change

-94.68%

10 Year Change

-98.37%

Max Change

-99.15%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment